These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 19203058

  • 1. [Nephrogenic systemic fibrosis--new clinical entity].
    Prvulović M.
    Med Pregl; 2008; 61(9-10):439-41. PubMed ID: 19203058
    [Abstract] [Full Text] [Related]

  • 2. [Nephrogenic systemic fibrosis].
    Breitschaft A, Stahlmann R.
    Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227
    [Abstract] [Full Text] [Related]

  • 3. Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agents.
    Pietsch H, Lengsfeld P, Steger-Hartmann T, Löwe A, Frenzel T, Hütter J, Sieber MA.
    Invest Radiol; 2009 Apr; 44(4):226-33. PubMed ID: 19252439
    [Abstract] [Full Text] [Related]

  • 4. [Nephrogenic systemic fibrosis and use of MR contrast media].
    Christiansen RE, Sviland L, Sekse I, Svarstad E.
    Tidsskr Nor Laegeforen; 2009 Jan 29; 129(3):180-2. PubMed ID: 19180161
    [Abstract] [Full Text] [Related]

  • 5. Effects of gadolinium contrast agents in naïve and nephrectomized rats: relevance to nephrogenic systemic fibrosis.
    Grant D, Johnsen H, Juelsrud A, Løvhaug D.
    Acta Radiol; 2009 Mar 29; 50(2):156-69. PubMed ID: 19160079
    [Abstract] [Full Text] [Related]

  • 6. Nephrogenic systemic fibrosis: clinical picture and treatment.
    Marckmann P, Skov L.
    Radiol Clin North Am; 2009 Sep 29; 47(5):833-40, vi. PubMed ID: 19744598
    [Abstract] [Full Text] [Related]

  • 7. Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposure.
    Grobner T, Prischl FC.
    Semin Dial; 2008 Sep 29; 21(2):135-9. PubMed ID: 18226001
    [Abstract] [Full Text] [Related]

  • 8. Nephrogenic systemic fibrosis: more questions and some answers.
    Morcos SK, Thomsen HS.
    Nephron Clin Pract; 2008 Sep 29; 110(1):c24-31; discussion c32. PubMed ID: 18688172
    [Abstract] [Full Text] [Related]

  • 9. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
    Broome DR.
    Eur J Radiol; 2008 May 29; 66(2):230-4. PubMed ID: 18372138
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis.
    Peak AS, Sheller A.
    Ann Pharmacother; 2007 Sep 29; 41(9):1481-5. PubMed ID: 17684032
    [Abstract] [Full Text] [Related]

  • 11. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
    Sieber MA, Pietsch H, Walter J, Haider W, Frenzel T, Weinmann HJ.
    Invest Radiol; 2008 Jan 29; 43(1):65-75. PubMed ID: 18097279
    [Abstract] [Full Text] [Related]

  • 12. Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation.
    Wilford C, Fine JD, Boyd AS, Sanyal S, Abraham JL, Kantrow SM.
    Am J Dermatopathol; 2010 Feb 29; 32(1):71-5. PubMed ID: 19940755
    [Abstract] [Full Text] [Related]

  • 13. Nephrogenic systemic fibrosis: a review of the new conundrum.
    Goenka AH, Das CJ, Sharma R.
    Natl Med J India; 2009 Feb 29; 22(6):302-6. PubMed ID: 20384019
    [Abstract] [Full Text] [Related]

  • 14. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
    Kay J.
    Ann Rheum Dis; 2008 Dec 29; 67 Suppl 3():iii66-9. PubMed ID: 19022818
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of NSF: New evidence challenging the prevailing theory.
    Newton BB, Jimenez SA.
    J Magn Reson Imaging; 2009 Dec 29; 30(6):1277-83. PubMed ID: 19937925
    [Abstract] [Full Text] [Related]

  • 16. Nephrogenic systemic fibrosis and its impact on abdominal imaging.
    Prince MR, Zhang HL, Prowda JC, Grossman ME, Silvers DN.
    Radiographics; 2009 Oct 29; 29(6):1565-74. PubMed ID: 19959508
    [Abstract] [Full Text] [Related]

  • 17. Nephrogenic systemic fibrosis: histology and gadolinium detection.
    Thakral C, Abraham JL.
    Radiol Clin North Am; 2009 Sep 29; 47(5):841-53, vi-vii. PubMed ID: 19744599
    [Abstract] [Full Text] [Related]

  • 18. The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report.
    Wiedemeyer K, Kutzner H, Abraham JL, Thakral C, Carlson JA, Tran TA, Hausser I, Hartschuh W.
    Am J Dermatopathol; 2009 Oct 29; 31(7):674-81. PubMed ID: 19633532
    [Abstract] [Full Text] [Related]

  • 19. Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review.
    Sanyal S, Marckmann P, Scherer S, Abraham JL.
    Nephrol Dial Transplant; 2011 Nov 29; 26(11):3616-26. PubMed ID: 21441397
    [Abstract] [Full Text] [Related]

  • 20. Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis.
    Thakral C, Abraham JL.
    J Cutan Pathol; 2009 Dec 29; 36(12):1244-54. PubMed ID: 19602073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.